FDG-PET markers of heterogeneity and different risk of progression in amnestic MCI.
Silvia Paola CaminitiSilvia De FrancescoGiacomo TondoAlice GalliAlberto RedolfiDaniela Peraninull nullnull nullPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)
Algorithm based on FDG-PET hypometabolism demonstrates distinct subtypes across aMCI; Three different subtypes show heterogeneous biological profiles and risk of progression; The cortical hypometabolism is associated with AD pathology and cognitive decline; MTL hypometabolism is associated with the lowest conversion rate and CSF-AD pathology.